Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis

NCT: NCT04178161 · TERMINATED

NCT IDNCT04178161
StatusTERMINATED
Start Date2016-09-01
Completion2021-05-01
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

Hyperhidrosis is a condition in which sweating is in excess of that required for normal regulation of body temperature. Commonly affected areas in primary hyperhidrosis include axillae, palms and soles. Secondary hyperhidrosis can affect scalp, face, neck, back, groin and legs. Hyperhidrosis can negatively impact, employment, relationships, or other aspects of quality of life. The investigators propose to investigate the use of a unique image-guided laser to specifically ablate eccrine sweat glands.

Frequently Asked Questions

What is Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis?

Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis is a clinical trial registered under NCT04178161. Current status: TERMINATED.

What is the status of NCT04178161?

The current status of NCT04178161 (Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis) is: TERMINATED.

When did Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis start?

Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis started on 2016-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.